• Features of the clinical course of uterine fibroids of reproductive age women

Features of the clinical course of uterine fibroids of reproductive age women

HEALTH OF WOMAN. 2018.5(132):102–106; doi 10.15574/HW.2018.132.102

Flaksemberg M. A.
SI «Institute of Pediatrics, Obstetrics and Gynecology acad. O.M. Lukyanovaya NAMNU», Kyiv

The objective: in this work represented part of materials of department rehabilitation of reproductive function for the examination and treatment of 250 patients with uterine fibrods in order to study and determine in detail the predictors of the disease, develop methods of treatment (conservative and surgical), as well as rehabilitation of the reproductive function, depending on the type and localization of the nodes.

Materials and methods. The analysis of the anamnestic data, taking into account both objective and subjective data, analysis of anamnestic data of close relatives (maternal and paternal lines), concomitant genital and extragenital pathology is carried out.

Results. The most numerical group of patients with uterine fibroids, according to our data, in the age groups of 26–35 years (32%) is 36–40 years (28.4%), which are the most socially and reproductively active. In this category, women with a high education of 33.6% and social status (30.4% and 22.4%) prevailed. The transferred inflammatory diseases of the genitals were noted in 48% of the examined, weighed gynecological anamnesis (abortions, miscarriages) were noted in 42.4%.

Conclusion. Also for this category of patients is characterized by a high percentage of endometrial pathology – 60.8%, as well as concomitant adenomyosis – 34% and adhesion process of pelvic organs – 26.8%.

Key words: clinical course, uterine fibroids, reproductive age.

REFERENCES

1. Kornatska AH, Raksha II, Kolesnichenko IS, Chubei HV. 2015. Suchasni pohliady na etiolohiiu, patohenez ta likuvannia leiomiomy matky u zhinok reproduktyvnoho viku (Ohliad literatury). Zdorove zhenshchіnу 1(97):10–12.

2. Kornatska AH, Kolesnichenko IS, Flaksemberh MA, Revenko OO. 2014. Osoblyvosti anatomo-funktsionalnoho stanu orhaniv maloho taza ta heneratyvnoi funktsii u zhinok z leiomiomoiu matky. Zdorove zhenshchіnу. K. 10(96):134–136.

3. Doherty L, Mutlu D, Sinclair D, Taylor H. 2014. Uterine fibroids: clinical manifestations and contemporary management. Reprod Sci. 21:1067–1092. https://doi.org/10.1177/1933719114533728; PMid:24819877

4. Wise LA, Laughlin-Tommaso SK. 2016, Mar. Epidemiology of Uterine Fibroids: From Menarche to Menopause. Clin. Obstet. Gynecol. 59(1):2–24. https://doi.org/10.1097/GRF.0000000000000164; PMid:26744813 PMCid:PMC4733579

5. Veropotvelyan PN, Veropotvelyan NP, Tsehsmistrenko IS, Bondarenko AA. 2016. Sovremennoe predstavlenie o miome matki i ee lechenii. Zdorove zhenschiny. K. 7(113):16–22.

6. Styer AK, Rueda BR. 2016, Jul. The Epidemiology and Genetics of Uterine Leiomyoma. Best Pract. Res. Clin. Obstet. Gynecol. 34:3. https://doi.org/10.1016/j.bpobgyn.2015.11.018; PMid:26725703

7. Hoida NH, Moiseienko RO, Maistruk HP. 2016. Osnovni dosiahnennia vykonannia Derzhavnoi prohramy «R» za 2005–2015 r. Zdorove zhenshchіnу 4:14–16.

8. Zhylka NIa. 2016. Innovatsiini pidkhody do likuvannia leiomiomy matky. Zdorove zhenshchinу. K. 7(113):104–106.

9. Sangkomkamhang US, Lumbiganon P, Laopaiboon M, Mol BW. 2013. Progestogens or progestogen-releasing intrauterine systems for uterine fibroids. Cochrane Database Syst Rev. 2:CD008994. https://doi.org/10.1002/14651858.CD008994.pub2

10. Kulakov VI. 2014. Novyie podhodyi k lecheniyu miomyi matki. Mnenie eksperta. Problemy reproduktsii 2:57–58.

11. Yerushalmi GM, Gilboa Y, Jakobson-Setton A, Tadir Y, Goldch-mit C, Kats D, Seidman DS. 2014. Vaginal mifepristone for the treatment of symptomatic uterine leomyomata: an open-label study. Fertil Steril. 101:496–500. https://doi.org/10.1016/j.fertnstert.2013.10.015; PMid:24220703

12. Radzinskiy VE, Fatkulin IF, Bakanova AR, Dobretsova TA. 2014. Mioma matki: ot diskussiy k innovatsiyam. Prakticheskie rekomendatsii. M, Redaktsiya zhurnala Status Praesens:16.

13. Lebedev VA, Davyidov AI, Pashkov VM. 2013. Spornyie i nereshennyie voprosyi lecheniya i profilaktiki miomyi matki u bolnyih reproduktivnogo perioda. Trudnyiy patsient 11(8–9):14–19.

14. Zvyichaynyiy MA, Vorontsova AV, Chilova AL, Fedotovskih IV. 2014. Giperplasticheskiy sindrom reproduktivnoy sistemy u zhenschin v perimenopauze: taktika konservativnoy terapii i reabilitatsii. Ginekologiya 1:44–48.